US 7943318
Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
granted A61PA61P35/00
Quick answer
US patent 7943318 (Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P35/00